Novo Nordisk
NVO
$5,673
Share price
9.12%
Change (1 day)
-17.81%
Change (1 year)
Categories
Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
Earnings for Novo Nordisk (NVO)
Earnings in 2025 (TTM): $1.797 Trillion
According to Novo Nordisk's latest financial reports the company's current earnings are $47.21 Billion. In 2024 the company made an earning of $1.722 Trillion, an increase over its 2023 earnings that were of $1.402 Trillion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Novo Nordisk from 1984 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | $1.797 T | 4.33% |
| 2024 | $1.722 T | 22.84% |
| 2023 | $1.402 T | 57.81% |
| 2022 | $888.66 B | 5.24% |
| 2021 | $844.44 B | 12.38% |
| 2020 | $751.40 B | 13.11% |
| 2019 | $664.32 B | -3.45% |
| 2018 | $688.05 B | 1.88% |
| 2017 | $675.33 B | 4.3% |
| 2016 | $647.47 B | 10.32% |
| 2015 | $586.89 B | 7.47% |
| 2014 | $546.11 B | 3.4% |
| 2013 | $528.15 B | 19.09% |
| 2012 | $443.50 B | 15.58% |
| 2011 | $383.73 B | 16.58% |
| 2010 | $329.16 B | 25.66% |
| 2009 | $261.95 B | 10.68% |
| 2008 | $236.68 B | 55.82% |
| 2007 | $151.89 B | 7.02% |
| 2006 | $141.93 B | 19.05% |
| 2005 | $119.22 B | 10.55% |
| 2004 | $107.84 B | |
| 2002 | $74.27 B | -14.39% |
| 2001 | $86.76 B | -52.82% |
| 2000 | $183.87 B | 250% |
| 1999 | $52.53 B | 31.21% |
| 1998 | $40.03 B | 34.31% |
| 1997 | $29.81 B | 11.46% |
| 1996 | $26.74 B | 9.03% |
| 1995 | $24.52 B | -3.15% |
| 1994 | $25.32 B | -0.67% |
| 1993 | $25.49 B | 45.38% |
| 1992 | $17.53 B | -13.81% |
| 1991 | $20.34 B | 37.12% |
| 1990 | $14.83 B | -0.79% |
| 1989 | $14.95 B | 26.2% |
| 1988 | $11.85 B | 24.97% |
| 1987 | $9.48 B | -0.9% |
| 1986 | $9.57 B | -7.78% |
| 1985 | $10.37 B | 24.87% |
| 1984 | $8.31 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $1.078 T | -43.14% | ๐บ๐ธ USA |
 Eli Lilly LLY | $2.048 T | 7.95% | ๐บ๐ธ USA |
 Bristol-Myers Squibb BMY | $731.18 B | -61.46% | ๐บ๐ธ USA |
 Sanofi SNY | $828.32 B | -56.34% | ๐ซ๐ท France |